Hepatocellular Carcinoma Rupture after Introducing Lenvatinib: An Autopsy Case Report-Reference-Cited by-同舟云学术

Hepatocellular Carcinoma Rupture after Introducing Lenvatinib: An Autopsy Case Report

Published:2023-04-01 Issue:7 Volume:62 Page:995-998
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Kohya Risako¹,Sugiura Ryo¹,Yamamoto Yoshiya¹,Naruse Hirohito¹,Hatanaka Kazuteru¹,Kinoshita Kenji¹,Abiko Satoshi¹,Miyamoto Shuichi¹,Suzuki Kazuharu¹,Kushibiki Hanae²,Munakata Satoru²,Shimoyama Norihiko²

Affiliation:

1. Department of Gastroenterology and Hepatology, Hakodate Municipal Hospital, Japan

2. Department of Pathology, Hakodate Municipal Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/62/7/62_0114-22/_pdf

Reference13 articles.

1. 1. Bruix J, Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology 53: 1020-1022, 2011.

2. 2. European Association for the Study of the Liver. EASL Clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 69: 182-236, 2018.

3. 3. Kudo M, Finn RS, Qin S, et al. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Lancet 24: 1163-1173, 2018.

4. 4. Sho T, Suda G, Ogawa K, et al. Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real-world setting. JGH Open 10: 54-60, 2019.

5. 5. Higashino M, Sugiura R, Yamamoto Y, Naruse H, Sakamoto N. A spontaneous rupture of lung metastasis from hepatocellular carcinoma after the introduction of lenvatinib. J Gastrointestin Liver Dis 13: 169-170, 2021.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Case of Giant Hepatocellular Carcinoma Successfully Treated with Lenvatinib Followed by Parenchymal-Sparing Hepatectomy;The Japanese Journal of Gastroenterological Surgery;2023-10-01

2. Lenvatinib;Reactions Weekly;2023-05-13